Investigation of Imatinib (Alpha Form)
Martin
Vickers
2nd December 2009
Experimental Data
Click image to access powder diffraction data (.spf format)
Chemical Name
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Chemical Formula
C29H31N7O |
 |
Preparation and Instrumentation Parameters
- Stoe StadiP transmission (capillary) Powder Diffractometer
- Cu Kα1 X-ray radiation
- Pre-sample germanium monochromator
- 40kV/25mA generator power
- Linear Position Sensitive Detector 6° 2θ range
- Rotating 0.5mm sample capillary
- uncrushed unsieved sample
- NBS Silicon (111 reflection) calibration
- Data aquisition details:
- Date collected: 27/11/09
- File: ST3996.RAW
- ×2 ranges from 2 to 35° 2θ and summed
- PSD step: 0.2°
- Count Time: 150 seconds per step
- Binning: 4 channels per point
- Data Step: 0.02°
Results
- Indexed using Kohl
- Refined lattice parameters by Lebail fit:
| Unit Cell Lengths (Å): |
|
a 9.881(1) |
b 18.105(1) |
c 9.488(1) |
| Unit Cell Angles (°): |
|
α 89.412(1) |
β 117.382(1) |
γ 99.064(1) |
| Unit Cell Volume (Ų): |
| 1485 |
- Z: 2
- System: Triclinic
- Possible Space Group: P-1
Reference
Patent Applcation: WO09903854A1
----------